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performed using CP-H associated with ESR, dihydroethidium (DHE) oxidative fluores-
cence and immunohistochemistry (gp91phox and p22phox).
Results: During the pre-ischemic period, an aged-related decrease in myocardial func-
tional parameters (coronary flow, left ventricular developed pressure, heart rate) was
observed. After ischemia, we noted a partial functional recovery which was higher in Y
hearts compared with A and O hearts (respectively 17.0±2.2, 5.0±2.8, 5.4±2.6 % of the
preischemic values). Our results showed a large release of oxidized CP-H (CP•) during
the first minutes of reperfusion which was increased with age (1,296±164 AU in Y hearts,
2,052±188 AU in A hearts, 2,425±405 AU in O hearts). The activity and expression of the
vascular NADPH oxidase increased with age according to the ESR approach (14±1 AU
in Y group, 20±3 AU in A group, 33±4 AU in O group), fluorescence microscopy (DHE)
and immunohistochemistry for gp91phox (0.7±0.1 AU in Y group, 1.5±0.1 AU in A group,
2.1±0.1 AU in O group) and p22 phox; NADPH oxidase involved in these changes being
localized in endothelial cells.
Conclusion: Our study suggests that myocardial function and adaptation to ischemia-
reperfusion decrease during aging and is related to an higher level of oxidative stress.
Endothelial NADPH oxidase appears to be an important contributor to the age-related
cardiovascular deterioration.
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Background The significance of body mass index (BMI) in pts with acute myocardial inf-
arction (AMI) undergoing primary percutaneous coronary intervention (PCI) is unknown.
Methods and Results. In the CADILLAC trial, 2035 pts undergoing primary PCI for AMI
were divided into 3 groups based on BMI: non-obese (<25), mildly obese (>25 to <30)
and very obese (>30 kg/m2). Non-obese pts were older, more frequently female, and had
higher rate of intervention on LAD, while very obese pts had higher prevalence of diabe-
tes and hyperlipidemia. Target vessel reference diameter was smaller in non-obese
(median 2.89 mm) compared to mildly obese (3.01 mm, P<0.0001) and very obese pts
(3.05mm, P<0.0001), while number of diseased vessels and ejection fraction did not dif-
fer among the groups. The rates of 1-year mortality and of disabling stroke were highest
in non-obese pts (Table). However, by multivariate analysis, non-obese pts were not at
increased risk of mortality compared with mildly obese (HR=0.68, 95% CI 0.35, 1.32) and
severely obese pts (HR=0.55, 95% CI 0.22, 1.34). Rather, predictors of 1-year mortality
included age (P=0.0002), LAD infarct vessel (P=0.002), and reduced ejection fraction
(P<0.0001). Conclusions. Compared to obese pts, the 1-year prognosis of pts with low-
normal BMI is significantly worse after primary PCI for AMI. This apparent “obesity para-
dox” may be explained by the fact that non-obese pts presenting with AMI are older and
more frequently have anterior infarction than their obese counterparts.
1002-83 Prognostic Indications of a Novel Biological Marker of 
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Guillaume Lefevre, Aigline Lefranc, Eric Garbarz, Eric Bouvard, Hanafi Graine, Frank 
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Background: Ischemia Modified Albumin (IMA™) measured by the Albumin Cobalt
Binding (ACB®) test (Ischemia Technologies, Denver, CO, USA) is a new quantitative
biomarker which measures cobalt binding capacity of albumin modified as a result of
myocardial ischemia. This study was conducted to investigate IMA in patients presenting
with chest pain and assess its relationship to cardiac outcome at 6 weeks.
Methods: 95 patients (60 + 17 yrs, 56 males) with chest pain at presentation were stud-
ied. Serum samples were collected and traditional cardiac necrosis markers (total CK
activity, CKMB, Troponin I (cTnI), Myoglobin) as well as IMA (measured on the KoneLab
20) were determined. Serum for IMA was separated and stored at –20°C prior to analy-
sis. Cut-off values for CK, CKMB, cTnI, Myoglobin and ACB were 180 U/L, 10 U/L, 0.25
µg/L, 110 µg/L and 85 U/mL, respectively.
Results: Time from chest pain onset to presentation was less than 1 hour in 8 patients
(8.5%), 1-2 hours in 15 patients (16%), 2-3 hours in 26 patients (27%), 3-6 hours in 13
patients (13.8%), 6-12 hours in 25 patients (26.5%), and >12 hours in 7 patients (7.2%).
Myoglobin was elevated in 17 patients (17.8 %), total CK in 24 patients (25.3 %) and cTnI
in 14 patients (14.7%) consistent with a high risk population arriving late with respect to
pain onset. IMA (100 + 10 U/mL) was elevated in 84 patients (88%). There was no corre-
lation between IMA and any necrosis marker. When considering adverse cardiac events
at 6 weeks (ischemic ECG changes, cTnI increase, MI, revascularisation and death due
to cardiac complication), presentation IMA sensitivity was 97.5% (95% CI: 86.8-99.6%),
specificity was 17.9% (95% CI: 8.9-30.4%) and NPV was 90.9% (95% CI: 74-100%). IMA
was significantly lower in 57 patients with no complications (95 + 11 U/mL) versus 12
patients with follow-up complications (103 + 7 U/mL), p < 0.05.
Conclusions: Our results show that IMA is a highly sensitive marker for coronary syn-
dromes even in patients with normal cardiac necrosis marker values, however, it is non-
specific. Negative predictive value is high for safe rule-out. IMA could be a useful tool for
predicting future cardiac complications in patients with chest pain in the emergency set-
ting.
1002-84 Eplerenone Normalizes Diastolic Relaxation and 
Extracellular Matrix Accumulation in Aged Rats With 
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Background: The incidence and severity of CVdiseases increase rapidly with age.
Aldosterone blockers have shown benefits in patients with LV dysfunction after MI and in
HF. However, efficacy of these agents in experimental models of MI in aged animals has
not been explored. Methods: 16-month old rats were divided into controls (sham, n= 9),
MI (coronary artery ligation, n= 9) and MI with eplerenone in diet (MI + Eple, 120 mg/kg/
d, n= 9). Treatment started 18 days after surgery, until sacrifice 3 months later. LV func-
tion and dimensions were investigated by echocardiography and hemodynamics. Cardiac
fibrosis and the elastin-to-collagen ratio in thoracic aorta were evaluated by histology.
Results: Untreated MI rats had systolic impairment (LVEF: 58 ± 8 vs. 73 ± 2 % in con-
trols, p< 0.05) and clear evidence of diastolic dysfunction (increase of E wave decelera-
tion time DT, and decrease of E wave velocity from 73 ± 3 to 63 ± 5 cm/s (p< 0.05),
increase of isovolumic relaxation time from 22 ± 2 to 28 ± 3 ms). LV relaxation was
depressed in MI rats (-dP/dt: -33%). Cardiac interstitial fibrosis increased by 23%, while
aorta elastin-to-collagen ratio decreased by 40% (Figure). Eplerenone normalized
echocardiographic and hemodynamic parameters of diastolic relaxation, cardiac intersti-
tial fibrosis and elastin-to-collagen ratio in aorta (Figure). Conclusion: Eplerenone was
well tolerated by aged rats. Aldosterone blockade normalized diastolic relaxation after MI,
and blunted cardiac and aortic collagen accumulation.
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INTRODUCTION: In patients with acute myocardial infarction undergoing primary percu-
taneous coronary intervention (PCI) the presence of preinfarction angina (PA), clinical
sign of the phenomenon known as “ischemic preconditioning”, has been shown to exert
in the ischemic myocardium a protective effect on left ventricular function. Whether the
same occurs in diabetic patients (DP) remains unknown.
METHODS: We studied 183 nondiabetic patients (NDP) (mean age 67 years, 29%
female) and 153 DP (age 69 years, 39% female), hospitalized in our Coronary Care Unit
for a first ST-segment elevation acute myocardial infarction and treated with successful
PCI on the culprit lesion (TIMI 3 flow restored). 2D-echocardiographic left ventricular
ejection function (LVEF) on admission was compared with LVEF at hospital discharge.
Time from angina pectoris to balloon (TAB), ST-segment resolution >50%, T-wave inver-
sion after PCI, CK-MB peak and in-hospital events were compared in both groups.
RESULTS: In the study population, PA was found in 137 subjects (mean age 67 years,
35% female, 62 DP). When PA was present, creatine kinase peak was sensibly lower in
NDP (986 vs 1659 UI/L p=0.025) with earlier ST-segment resolution (9.5 vs 18.3 hours
p=0.009) and T-wave inversion (90 minutes after PCI: 62.0% vs 37.3% p=0.007), while
no differences were instead observed in diabetic ones (all p=ns). Furthermore, in DP an
inverse correlation was evidenced between LVEF after PCI and TAB (R=-0.47 p=0.019)
but not in NDP with PA (R=-0.23 p=ns). At discharge, LVEF improvement was superior in
NDP (+13.6% vs +8.9% p=ns) especially when PA was present (+21.6% vs 8.1%
p=0.041), while in DP with PA no differences were evidenced (+8.5% vs +9.3% p=ns).
Similarly, PA was associated to reduced incidence of left ventricular expansion (4.0% vs
14.9% p=0.049) and cardiac failure (12.0% vs 26.9% p=0.035) only in NDP.
CONCLUSIONS: Our results suggest that in diabetic patients with acute myocardial inf-
arction treated with percutaneous coronary intervention, PA do not induce protective
effects in the ischemic myocardium, probably due to loss of myocyte preconditioning
which reduces tolerance to ischemia and worsens left ventricular function.
Endpoint, % Body mass index (kg/m2)  P-value*
 <25.0
 N=552
>25.0 to<30.0
 N=915
>30.0
 N=568
Death  7.5  3.6 1.8  <0.0001
Any MI  1.9  2.4 2.7  0.68
Ischemic TVR  11.4  13.8 14.5  0.27
Disabling stroke  1.4 0.1 0.4  0.006
Any MACE  18.9 17.1 17.0  0.65
*By analysis of variance. TVR=target vessel revascularization. MACE=major adverse 
cardiac events
